Arian Emami Riedmaier
Overview
Explore the profile of Arian Emami Riedmaier including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
448
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Emami Riedmaier A, Bies R
J Pharmacokinet Pharmacodyn
. 2024 Sep;
51(5):397.
PMID: 39312058
No abstract available.
2.
Kesisoglou F, Basu S, Belubbi T, Bransford P, Chung J, Dodd S, et al.
AAPS J
. 2023 Jun;
25(4):60.
PMID: 37322223
Current regulatory guidelines on drug-food interactions recommend an early assessment of food effect to inform clinical dosing instructions, as well as a pivotal food effect study on the to-be-marketed formulation...
3.
Shoyaib A, Emami Riedmaier A, Kumar A, Roy P, Parrott N, Fang L, et al.
CPT Pharmacometrics Syst Pharmacol
. 2023 Jan;
12(5):610-618.
PMID: 36597353
This workshop report summarizes the presentations and panel discussion related to the use of physiologically based pharmacokinetic (PBPK) modeling approaches for food effect assessment, collected from Session 2 of Day...
4.
Petersson C, Zhou X, Berghausen J, Cebrian D, Davies M, DeMent K, et al.
AAPS J
. 2022 Jul;
24(5):85.
PMID: 35854202
Accurate prediction of human clearance (CL) and volume of distribution at steady state (V) for small molecule drug candidates is an essential component of assessing likely efficacious dose and clinical...
5.
6.
Hariparsad N, Ramsden D, Taskar K, Badee J, Venkatakrishnan K, Reddy M, et al.
Clin Pharmacol Ther
. 2021 Dec;
112(4):770-781.
PMID: 34862964
The International Consortium for Innovation and Quality (IQ) Physiologically Based Pharmacokinetic (PBPK) Modeling Induction Working Group (IWG) conducted a survey across participating companies around general strategies for PBPK modeling of...
7.
Kikuchi R, Chiou W, Durbin K, Savaryn J, Ma J, Emami Riedmaier A, et al.
Drug Metab Dispos
. 2021 Jul;
49(10):938-946.
PMID: 34330717
The successful prospective incorporation of in vitro transporter kinetics in physiologically based pharmacokinetic (PBPK) models to describe drug disposition remains challenging. Although determination of scaling factors to extrapolate in vitro...
8.
Wagner C, Kesisoglou F, Pepin X, Parrott N, Emami Riedmaier A
AAPS J
. 2021 Jun;
23(4):85.
PMID: 34142242
Food can alter drug absorption and impact safety and efficacy. Besides conducting clinical studies, in vitro approaches such as biorelevant solubility and dissolution testing and in vivo dog studies are...
9.
Pepin X, Huckle J, Alluri R, Basu S, Dodd S, Parrott N, et al.
AAPS J
. 2021 Jan;
23(1):12.
PMID: 33398593
Over the last 10 years, 40% of approved oral drugs exhibited a significant effect of food on their pharmacokinetics (PK) and currently the only method to characterize the effect of...
10.
Emami Riedmaier A, DeMent K, Huckle J, Bransford P, Stillhart C, Lloyd R, et al.
AAPS J
. 2020 Nov;
23(1):6.
PMID: 33244667
An Erratum to this paper has been published: https://doi.org/10.1208/s12248-020-00535-z.